FDA Inspection 1107587 — Boehringer Ingelheim Pharma GmbH & Co. Kg

Boehringer Ingelheim Pharma GmbH & Co. Kg — FEI 3002806518

The FDA completed an inspection of Boehringer Ingelheim Pharma GmbH & Co. Kg on August 15, 2019 in Biberach An Der Riss. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 15, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Biberach An Der Riss (Germany)

Additional Details

Clinical BA/BE